[[1]] Eastwood G, Bellomo R, Bailey M, et,al. Arterial oxygen tension and mortality in mechanically ventilated patients. Intensive Care Med 2012; 38: 91-98. DOI: 10.1007/s00134-011-2419-6.
[2] Suzuki S, Eastwood GM, Peck L, et,al. Current oxygen management in mechanically ventilated patients: a prospective observational cohort study. J Crit Care 2013;28: 647-654. DOI: 10.1016/j.jcrc.2013.03.010.
[3] de Graaff AE, Dongelmans DA, Binnekade JM, et,al. Clinicians' response to hyperoxia in ventilated patients in a Dutch ICU depends on the level of FiO2. Intensive Care Med 2011; 37: 46-51. DOI: 10.1007/s00134-010-2025-z.
[4] Suzuki S, Mihara Y, Hikasa Y, et,al. Current Ventilator and Oxygen Management during General Anesthesia: A Multicenter, Cross-sectional Observational Study. Anesthesiology 2018; 129: 67-76. DOI: 10.1097/ALN.0000000000002181.
[5] Dias-Freitas F, Metelo-Coimbra C, Roncon-Albuquerque R Jr, et,al. Molecular mechanisms underlying hyperoxia acute lung injury. Respir Med 2016; 119: 23-28. DOI:10.1016/j.rmed.2016.08.010.
[6] Asfar P, Schortgen F, Boisramé-Helms J, et,al. Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial. Lancet Respir Med 2017; 5: 180-190. DOI: 10.1016/S2213-2600(17)30046-2.
[7] Sabaté S, Mazo V, Canet J. Predicting postoperative pulmonary complications:implications for outcomes and costs. Curr Opin Anaesthesiol 2014; 27: 201-209.DOI:10.1097/ACO.0000000000000045.
[8] Barkauskas CE, Cronce MJ, Rackley CR, et,al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest 2013; 123: 3025-3036. DOI: 10.1172/JCI68782.
[9] Chroneos ZC, Sever-Chroneos Z, Shepherd VL. Pulmonary surfactant: an immunological perspective. Cell Physiol Biochem 2010; 25: 13–26. DOI: 10.1159/000272047.
[10] Tantawy AA, Adly AA, Ebeid FSE, et,al. Surfactant protein D as a marker for pulmonary complications in pediatric patients with sickle cell disease: Relation to lung function tests. Pediatr Pulmonol 2019; 54: 610-619. DOI: 10.1002/ppul.24257.
[11] Du J, Abdel-Razek O, Shi Q, et,al. Surfactant protein D attenuates acute lung and kidney injuries in pneumonia-induced sepsis through modulating apoptosis, inflammation and NF-κB signaling. Sci Rep 2018; 8: 15393. DOI: 10.1038/s41598-018-33828-7.
[12] Jin Y, Peng LQ, Zhao AL. Hyperoxia induces the apoptosis of alveolar epithelial cells and changes of pulmonary surfactant proteins. Eur Rev Med Pharmacol Sci 2018; 22: 492-497. DOI: 10.26355/eurrev_201801_14200.
[13] Basaran UN, Ayvaz S, Aksu B, et al. Desferrioxamine reduces oxidative stress in the lung contusion. Sci World J 2013; 2013: 376959. DOI: 10.1155/2013/376959.
[14] Hybertson BM, Connelly KG, Buser RT, et al. Ferritin and desferrioxamine attenuate xanthine oxidase-dependent leak in isolated perfused rat lungs. Inflammation 2002; 26: 153-159.DOI: 10.1023/a:1016511611435.
[15] Kletkiewicz H, Nowakowska A, Siejka A, et al. Deferoxamine prevents cerebral glutathione and vitamin E depletions in asphyxiated neonatal rats: role of body temperature. Int J Hyperthermia 2016; 32: 211-220. DOI: 10.3109/02656736.2015.1125955.
[16] Britt RD Jr, Velten M, Locy ML, et al. The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome. Antioxid Redox Signal 2014; 20: 2681-2691. DOI: 10.1089/ars.2013.5332.
[17] Kim SJ, Jung HJ, Hyun DH, et al. Glutathione reductase plays an anti-apoptotic role against oxidative stress in human hepatoma cells. Biochimie 2010; 92: 927-932. DOI: 10.1016/j.biochi.2010.03.007.
[18] Ozdemir R, Demirtas G, Parlakpinar H, et al. Dexpanthenol therapy reduces lung damage in a hyperoxic lung injury in neonatal rats. J Matern Fetal Neonatal Med 2016; 29: 1801-1807. DOI: 10.3109/14767058.2015.1064104.
[19] Fukuhara K, Nakashima T, Abe M, et,al. Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals. Free Radic Biol Med 2017; 106: 1-9.10.1016/j.freeradbiomed.2017.02.014.
[20] Dias-Freitas F, Metelo-Coimbra C, Roncon-Albuquerque R Jr. Molecular mechanisms underlying hyperoxia acute lung injury. Respir Med 2016; 119: 23-28. DOI: 10.1016/j.rmed.2016.08.010.
[21] Jaffal K, Six S, Zerimech F, et al. Relationship between hyperoxemia and ventilator associated pneumonia. Ann Transl Med 2017: 5: 453-457. DOI: 10.21037/atm.2017.10.15.
[22] Kawamura T, Wakabayashi N, Shigemura N, et al. Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo. Am J Physiol Lung Cell Mol Physiol 2013; 304: L646-L656. DOI: 10.1152/ajplung.00164.2012.
[23] Damiani E, Adrario E, Girardis M, et al. Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis. Crit Care 2014; 18: 711-726. DOI: 10.1186/s13054-014-0711-x.
[24] Ferguson ND, Fan E, Camporota L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012; 38: 1573-1582. DOI: 10.1007/s00134-012-2682-1.
[25] Ye Y, Lin P, Zhang W, et al. DNA repair interacts with autophagy to regulate inflammatory responses to pulmonary hyperoxia. J Immunol 2017; 198: 2844-2853. DOI: 10.4049/jimmunol.1601001.
[26] Veith AC, Bou AB, Jiang W, et al. Mice lacking the cytochrome P450 1B1 gene are less susceptible to hyperoxic lung injury than wild type. Toxicol Sci 2018; 165: 462-474. DOI: 10.1093/toxsci/kfy154.
[27] Lee HS, Kim CK. Effect of recombinant IL-10 on cultured fetal rat alveolar type II cells exposed to 65%-hyperoxia. Respir Res 2011;12: 68-82. DOI: 10.1186/1465-9921-12-68.
[28] Kim MJ, Ryu JC, Kwon Y, et al. Dual oxidase 2 in lung epithelia is essential for hyperoxia-induced acute lung injury in mice. Antioxid Redox Signal 2014; 21: 1803-1818. DOI: 10.1089/ars.2013.5677.
[29] Pace PW, Yao LJ, Wilson JX, et al. The effects of hyperoxia exposure on lung function and pulmonary surfactant in a rat model of acute lung injury. Exp Lung Res 2009;35: 380-398. DOI: 10.1080/01902140902745166.
[30] Jin H, Ciechanowicz AK, Kaplan AR, et al. Surfactant protein C dampens inflammation by decreasing JAK/STAT activation during lung repair. Am J Physiol Lung Cell Mol Physiol 2018; 314: L882-L892. DOI: 10.1152/ajplung.00418.2017.
[31] Sano H, Kuroki Y. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol Immunol 2005; 42: 279-287. DOI: 10.1016/j.molimm.2004.07.014.
[32] Wang B, Yang RN, Zhu YR, et al. Involvement of xanthine oxidase and paraoxonase 1 in the process of oxidative stress in nonalcoholic fatty liver disease. Molecular Medicine Reports 2017; 15: 387-395. DOI: 10.3892/mmr.2016.6025.
[33] Zhu Z, Du S, Du Y, et al. Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis. J Neurochem 2018; 144: 93-104. DOI: 10.1111/jnc.14250.
[34] Vlahakos D, Arkadopoulos N, Kostopanagiotou G, et al. Deferoxamine attenuates lipid peroxidation, blocks interleukin-6 production, ameliorates sepsis inflammatory response syndrome, and confers renoprotection after acute hepatic ischemia in pigs. Artif Organs 2012; 36: 400-408. DOI: 10.1111/j.1525-1594.2011.01385.x.
[35] Molina-Jijón E, Zarco-Márquez G, Medina-Campos ON, et al. Deferoxamine pretreatment prevents Cr(VI)-induced nephrotoxicity and oxidant stress: role of Cr(VI) chelation. Toxicology 2012; 291: 93-101. DOI: 10.1016/j.tox.2011.11.003.